Dozens of Knobbe Martens Partners Recognized in 2026 IAM Patent 1000 Guide
IRVINE, Calif., May 28, 2026 – Knobbe Martens, a leading intellectual property law firm, and its partners were once again recognized for excellence across patent law in the 2026 edition...
Federal Circuit Confirms Patent Eligibility of Gene Therapy Patent in Regenexbio Inc. v. Sarepta Therapeutics
Key Takeaway: Genetically engineered cultured host cells containing recombinant nucleic acids useful for gene therapy are patent-eligible for being markedly different from anything occurring in nature. In REGENXBIO Inc. v....
USPTO Launches PIER Pilot Program Creating New Pre-Examination Decision Point for PCT National Stage Applications
Key Takeaway: The USPTO’s new PIER Pilot Program requires applicants in selected PCT national stage applications to affirmatively decide whether to proceed with, delay, or abandon U.S. patent examination. Participation...